1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIBIB R01/R21 for Biomanufacturing Tools – 3D Bioprinting of Scaffolds is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH. NIH NIBIB funding includes R01 and R21 mechanisms for additive manufacturing of biomedical scaffolds and bioprinting of living constructs, directly aligned to polymer additive manufacturing and biomedical materials research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: US academic institutions, non‑profits. Confirm the full requirements in the official notice before applying.
The current listing shows varies (R01 typical ~$460K/year; R21 smaller). Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIBIB R01/R21 for Biomanufacturing Tools – 3D Bioprinting of Scaffolds accepts applications on a rolling basis — there is no single fixed deadline. Check the official notice for any cycle-specific review dates.
NIBIB R01/R21 for Biomanufacturing Tools – 3D Bioprinting of Scaffolds is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe April 14 SBIR/STTR reauthorization restarted NIH's small-business pipeline after the shutdown, but the real signal is the sequencing of the new Small Business 101 webinars: program overview June 9, budget July 14, foreign risk August 18.
Read articleNIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read article